Remicade Biosimilar CT-P13 Found Safe, Effective for IBD Treatment in Italian Study
News
CT-P13, a biosimilar of Remicade (infliximab), is safe and effective for the treatment of inflammatory bowel disease (IBD), a study suggests. The study, “Infliximab biosimilar CT-P13 is effective and safe ... Read more